What Happens to Your Body When You Stop Taking Wegovy

What the trial data tells us about stopping semaglutide

The clearest evidence comes from the STEP 1 withdrawal extension, which followed participants for 20 weeks after stopping semaglutide 2.4mg. Those who had lost an average of around 17% of body weight during the main trial regained about two-thirds of that within the extension period. By one year after stopping, most participants had returned to close to their starting weight. The STEP 1 trial itself, published in the New England Journal of Medicine, enrolled nearly 2,000 adults with obesity over 68 weeks, so the regain data reflects a large, well-monitored cohort, not a handful of cases.

This pattern is consistent with how semaglutide works. As a GLP-1 receptor agonist, it reduces appetite and slows gastric emptying while it is present in the body. Once the medicine clears, those mechanisms are no longer active. The NHS semaglutide medicines page notes that treatment is intended to be used alongside a reduced-calorie diet and increased physical activity, and that context matters a lot when treatment ends.

None of this means stopping is wrong. Circumstances change: pregnancy plans, surgery, cost, a clinical decision to review the approach. The point is to go in with realistic expectations rather than being caught off guard when your appetite picks up again before the next week is out.

Why hunger and cravings come back so quickly

Semaglutide has a half-life of roughly one week, which is why the injection is dosed weekly. After the last dose, levels in the body fall steadily over the following one to two weeks. As concentrations drop, the GLP-1 receptor stimulation that was dampening appetite fades proportionally. Most people notice hunger returning within days of what would have been their next injection day, and if you are curious about what semaglutide symptoms feel like from day one, that early picture helps explain just how quickly the medicine's effects can shift when it is no longer active.

This is not a rebound in any pharmacological sense, the body is not producing more hunger hormone than it did before treatment. It is simply returning to where it was. For people who have been on Wegovy for months, that baseline can feel more intense by contrast. If you are thinking about what your options look like in terms of ongoing private treatment, our guide on affording Wegovy covers cost planning honestly.

Gastrointestinal symptoms that were present at the start of treatment, such as nausea, generally resolve when stopping, so in that narrow sense, some people feel better physically in the first week or two after their last dose. Understanding what to expect from the symptoms of taking Wegovy helps to separate what is treatment-related from what is post-treatment.

Physical and psychological effects worth being prepared for

Beyond appetite, a few other changes are worth knowing about. Energy levels can shift. Some people report feeling more fatigued in the weeks after stopping, particularly if food intake increases quickly without a corresponding change in activity. Blood sugar regulation, especially relevant for people with prediabetes or type 2 diabetes, may alter as the GLP-1 effect on insulin response is withdrawn, your prescriber or GP should be informed if you are in that group.

Psychologically, the return of intrusive food thoughts can feel discouraging, particularly if the quieter relationship with food during treatment had felt like relief. This is worth naming rather than glossing over. Reading about what the symptoms of Wegovy actually are across the full course of treatment can help frame what is normal at different stages.

There is no recognised discontinuation syndrome specific to semaglutide in the clinical literature. Some people do report unexpected urinary symptoms after stopping, and it is worth knowing whether Wegovy can cause UTI symptoms so you are not left wondering if something unrelated is being attributed to the medicine. If you experience anything unexpected, severe, or persistent after stopping, reporting it to the MHRA via the Yellow Card scheme contributes to the ongoing safety picture for these medicines, and seeing your GP is always the right first step for anything that worries you.

Having a plan before you stop makes a real difference

The evidence points clearly toward weight regain as the most significant consequence of stopping Wegovy without a follow-on plan. NHS England's guidance on weight-management injections acknowledges that long-term lifestyle support is a core part of treatment, not an optional extra, and that this matters most when medicine is stopped or paused.

Practical planning might include a structured reduction in calorie intake before stopping rather than after; building physical activity into your daily routine while the appetite suppression is still working in your favour; and a clear conversation with your prescriber about what stopping looks like for your specific situation. Some people stop intentionally after reaching a stable weight and feel they can maintain it; others find they need to return to treatment. Neither outcome is a failure.

If you are weighing up whether to continue, pause or restart semaglutide, a prescriber can look at the full picture. You can check your eligibility and start a free consultation with our clinical team, a real prescriber reviews every case the same day, not a form-sifting algorithm. Our clinical lead's profile gives a sense of who is making those decisions.